AtriCure Inc ATRC
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if ATRC is a good fit for your portfolio.
News
-
AtriCure to Announce First Quarter 2024 Financial Results
-
AtriCure to Participate in the 23rd Annual Needham Virtual Healthcare Conference
-
AtriCure Reports Fourth Quarter 2023 and Full Year 2023 Financial Results
-
AtriCure to Announce Fourth Quarter and Full Year 2023 Financial Results and Participate in 2024 BTIG Medical Technology Conference
Trading Information
- Previous Close Price
- $22.88
- Day Range
- $22.37–23.10
- 52-Week Range
- $22.37–59.49
- Bid/Ask
- $22.96 / $23.14
- Market Cap
- $1.11 Bil
- Volume/Avg
- 141,834 / 716,592
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 3.00
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- 0.49%
Company Profile
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. The company also offers a variety of minimally invasive ablation devices and access tools to facilitate the growing trend in less invasive cardiac and thoracic surgery. Geographically, it generates a majority of its revenue from the United States.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Stock Style Box
- Small Growth
- Total Number of Employees
- 1,200
- Website
- https://www.atricure.com
Comparables
Valuation
|
Metric
|
ATRC
|
MMSI
|
ZIMV
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 23.90 | 10.41 |
Price/Book Value | 2.64 | 3.46 | 1.12 |
Price/Sales | 3.00 | 3.34 | 0.98 |
Price/Cash Flow | 52.78 | 19.51 | 13.21 |
Price/Earnings
ATRC
MMSI
ZIMV
Financial Strength
|
Metric
|
ATRC
|
MMSI
|
ZIMV
|
|---|---|---|---|
Quick Ratio | 2.55 | 3.81 | 0.84 |
Current Ratio | 3.57 | 5.45 | 2.78 |
Interest Coverage | −3.86 | 8.07 | −1.51 |
Quick Ratio
ATRC
MMSI
ZIMV
Profitability
|
Metric
|
ATRC
|
MMSI
|
ZIMV
|
|---|---|---|---|
Return on Assets (Normalized) | −5.85% | 9.43% | 14.12% |
Return on Equity (Normalized) | −7.57% | 14.77% | 31.63% |
Return on Invested Capital (Normalized) | −6.07% | 11.47% | 18.79% |
Return on Assets
ATRC
MMSI
ZIMV
Medical Instruments & Supplies Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ISRG
| Intuitive Surgical Inc | Pyrdbfyx | Tfrjd | $133.8 Bil | |
BDX
| Becton Dickinson & Co | Gtkfsjrc | Dllrf | $67.9 Bil | |
ALC
| Alcon Inc | Sybndtmrr | Qqvwwzn | $40.4 Bil | |
CLPBY
| Coloplast A/S ADR | Wkjppdxyl | Gvqrs | $29.4 Bil | |
WST
| West Pharmaceutical Services Inc | Dpqyhtjty | Rkvll | $28.5 Bil | |
RMD
| ResMed Inc | Dlgzfdkvp | Qjvhs | $27.2 Bil | |
BAX
| Baxter International Inc | Dvtqqbkl | Rkdykjx | $20.4 Bil | |
COO
| The Cooper Companies Inc | Tfdsmnjl | Gjyfrtn | $18.3 Bil | |
HOLX
| Hologic Inc | Rjpspxfz | Fcmbk | $18.2 Bil | |
TFX
| Teleflex Inc | Thl | Bbfvl | $9.9 Bil |